Regulation & law · 26/07/2012

Nektar Therapeutics Submits Application for New Controlled Substance, Seeking FDA Approval

Nektar Therapeutics has submitted a notice of application to the FDA for a new controlled substance, as part of its ongoing efforts to develop innovative treatments for various medical conditions.